HQ
  • About A*STAR
    • Corporate Profile
      • A*STAR Board Members
      • Senior Management
      • Organisation Structure
      • Corporate Social Responsibility
      • Diversity at A*STAR
      • A*STAR Sustainability
    • Annual Report
    • A*STAR Global Network
  • Research
    • About A*STAR Research
    • Funding Opportunities
    • S-SEAF
    • Research Ethics
    • Biomedical Research Council
    • Science and Engineering Research Council
    • Our People
      • Highly Cited Researchers
      • Honours and Accolades
  • Innovation & Enterprise
    • About I&E
    • Innovation Offerings
  • Scholarships
  • News
    • A*STAR News
      • Publicity Highlights
      • Press Releases
      • Features
      • Committee Of Supply (COS) Debate
    • Case Studies
    • Faces of A*STAR
    • National Survey of RIE
    • Connect with Us
  • Career
  • Home
  • News
  • A*STAR News
  • COVID-19 R&D
  • A*STAR News
    • Publicity Highlights
    • Press Releases
    • Features
    • Committee Of Supply (COS) Debate
  • Case Studies
  • Faces of A*STAR
  • National Survey of RIE
  • Connect with Us
Agency for Science, Technology and Research (A*STAR)
PartnershipsCareersSuppliersContact UsWhistleblowing
  • Report Vulnerability
  • Privacy Statement
  • Terms & Conditions
    • COVID-19 R&D

    AI Tool to Enhance COVID-19 Screening

    25 Sep 2020
    • Whatsapp
    • Telegram
    • Facebook
    • Twitter
    • Email
    • Linked In

    The COVID-19 pandemic has spurred physicians to adopt innovations such as artificial intelligence (AI) to fight the disease more effectively.

    Developed by A*STAR and Tan Tock Seng Hospital, the AI tool RadiLogic expedites the chest X-Ray screening process of patients suspected of having COVID-19 pneumonia. So that appropriate care can be given to them sooner, and more accurately.

    RadiLogic Infographic
    AI Tool to Enhance COVID-19 Screening